Collection |
Collections
Filters
-
Collection Type
-
-
Collection |
COVID-19 4 years on: editors’ choice of selected publications
While mortality associated with COVID-19 has reduced remarkably with the arrival and broad adoption of effective vaccines, it is still a major public health concern, with up to two million new infections reported annually. In this special collection, the editors of npj Vaccines identify articles that illustrate the amazing progress made, but also the challenges that still lay ahead.
Image: AdobeStock -
Collection |
Latest advances in brain tumor immunotherapy
This cross-journal Collection invites research on evolving concepts in brain tumor immunology and immunotherapy, seeking to inform next-generation therapeutic approaches for cancers in the brain.
Image: © [M] Gorodenkoff / stock.adobe.comOpen for submissions -
Collection |
Next-generation vaccines for infectious diseases
This cross-journal Collection welcomes submissions that propose technological advancements in vaccine/antigen design, target combinations, delivery systems for any pathogen groups, as well as adjunctive therapies.
Image: © [M] Prasanth / stock.adobe.com / Generated with AIOpen for submissions -
Collection |
Nobel Prize in Physiology or Medicine 2023
The 2023 Nobel prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.
Image: Springer Nature/The Nobel Foundation/Imagesource -
Collection |
Progress towards the Sustainable Development Goals
The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.
Image: © Springer NatureOpen for submissions -
Collection |
Mpox
Following the recent declaration from the World Health Organization that the ongoing monkeypox (now named mpox) outbreak is a Public Health Emergency of International Concern, the editorial teams at Nature Portfolio have curated a collection of relevant articles.
Image: NIAID -
Collection |
COVID-19 two years on: development and implementation of vaccines against SARS-CoV-2
On the second anniversary of the identification of the causative agent of COVID-19, the npj Vaccines editorial team looks back on two years of uncertainty, but also astounding progress. Here we highlight a few stand out articles, from early calls for new vaccines, through to development of many prototypes and licensed vaccines, and finally looking at new variants, novel immunisations strategies, basic immunology, and inequalities in vaccine uptake.
Image: © rost9 / stock.adobe.com -
Collection |
Leading Cancer Research
Access leading research selected by our editors from our range of journals publishing research in cancer and oncology.
-
Collection |
Recent advances in malaria vaccines
Despite a marked decrease in cases and mortality, malaria is still estimated to result in over 405,000 deaths annually. Although a first vaccine against P. falciparum malaria is being piloted, much work is still needed to achieve the Global Technical Strategy for Malaria 2016–2030, from the World Health Assembly, to reduce global malaria incidence and mortality rates 90% by 2030. The latest advances in malaria vaccine research are compiled in this collection.
-
Collection |
Leading Research in Neuroscience
Nature Partner Journals is an online-only, open access series of journals, collaborating with preeminent scientists and global partners to publish high-quality open access research across the applied and basic science disciplines, as well as multidisciplinary fields. Our editors invite you to access articles from our range of journals publishing research in neuroscience. Browse all articles below.